🇺🇸 FDA
Company

Oric

Oric Pharmaceuticals

ORIC pharma USA

Quick answer

Oric is a pharma company (ORIC) headquartered in SOUTH SAN FRANCISCO, CA, USA with 8 tracked pipeline programs.

Pipeline (8)

project

ORIC-114

Solid Tumors

Phase 2 · small_molecule · active

1 trials project

ORIC-101

Healthy Volunteers

Phase 1 · small_molecule · completed

2 trials project

ORIC-101

Prostatic Neoplasms

Phase 1 · small_molecule · terminated

1 trials project

ORIC-101

Solid Tumor

Phase 1 · small_molecule · terminated

1 trials project

ORIC-114

Food Effect in Healthy Participants

Phase 1 · small_molecule · completed

1 trials project

ORIC-114 Dose 1 + amivantamab

Solid Tumors

Phase 1 · small_molecule · active

1 trials project

ORIC-533

Relapsed or Refractory Multiple Myeloma

Phase 1 · small_molecule · completed

1 trials project

ORIC-944

Metastatic Prostate Cancer

Phase 1 · small_molecule · active

1 trials

Patents (8)

patent

US 12312339

Polo like kinase 4 inhibitors

Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12239729

TRPV3 agonists for the treatment of skin conditions

Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12054556

Anti-PD-L1 antibody and use thereof

Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12018043

CD73 inhibitors

Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12005080

Method for promoting proliferation of immune cells

Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11993655

Anti-PD-L1 antibody and use thereof

Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11858915

Polo like kinase 4 inhibitors

Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11807658

CD73 inhibitors

Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)